| Active, not recruiting | 3 | 1033 | NA | palifermin, rituximab, cyclophosphamide, cytarabine, daunorubicin hydrochloride, etoposide, fludarabine phosphate, imatinib mesylate, melphalan, mercaptopurine, methotrexate, nelarabine, pegaspargase, vincristine sulfate, allogeneic hematopoietic stem cell transplantation, total-body irradiation | University College, London | Leukemia, Mucositis, Oral Complications | 12/24 | 12/25 | | |
| Terminated | 1/2 | 12 | Europe | Selumetinib, AZD6244, Dexamethasone | University of Birmingham, Cancer Research UK, AstraZeneca | Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, Adult, Acute Lymphoblastic Leukemia, Pediatric, Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Recurrent | 05/23 | 05/23 | | |
